Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort

Alzheimer's and Dementia

Volumn 12, Issue 3, 2016, Pages 281-291

  Mielke, Michelle M ^a   Machulda, Mary M ^a   Hagen, Clinton E ^a   Christianson, Teresa J ^a   Roberts, Rosebud O ^a   Knopman, David S ^a   Vemuri, Prashanthi ^a   Lowe, Val J ^a   Kremers, Walter K ^a   Jack, Clifford R ^a   Petersen, Ronald C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Amyloid; APOE; Cognitive aging; Cohort studies; PET

Indexed keywords

AMYLOID; APOLIPOPROTEIN E; APOLIPOPROTEIN E4; PITTSBURGH COMPOUND B; 2-(4'-(METHYLAMINO)PHENYL)-6-HYDROXYBENZOTHIAZOLE; AMYLOID BETA PROTEIN; ANILINE DERIVATIVE; THIAZOLE DERIVATIVE;

ADULT; AGED; ARTICLE; COGNITION; COGNITION ASSESSMENT; COGNITIVE DEFECT; COGSTATE COMPUTERIZED BATTERY; EPISODIC MEMORY; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; AMYLOIDOSIS; COHORT ANALYSIS; DIAGNOSTIC IMAGING; GENETICS; METABOLISM; PHYSIOLOGY; PSYCHOMETRY; TIME FACTOR; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PEPTIDES; AMYLOIDOSIS; ANILINE COMPOUNDS; APOLIPOPROTEINS E; COGNITION; COHORT STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; PSYCHOMETRICS; THIAZOLES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84954288922     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2015.09.010     Document Type: Article

References (45)

1. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol 82 1991 239 259
2. L.M. Shaw, M. Korecka, C.M. Clark, V.M. Lee, and J.Q. Trojanowski Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics Nat Rev Drug Discov 6 2007 295 303
3. R.J. Bateman, C. Xiong, T.L. Benzinger, A.M. Fagan, A. Goate, N.C. Fox, and et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease N Engl J Med 367 2012 795 804
4. S.M. Resnick, J. Sojkova, Y. Zhou, Y. An, W. Ye, D.P. Holt, and et al. Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB Neurology 74 2010 807 815
5. D.S. Knopman, C.R. Jack Jr., H.J. Wiste, S.D. Weigand, P. Vemuri, V. Lowe, and et al. Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease Neurology 78 2012 1576 1582
6. M. Storandt, M.A. Mintun, D. Head, and J.C. Morris Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition Arch Neurol 66 2009 1476 1481
7. Y.Y. Lim, P. Maruff, R.H. Pietrzak, K.A. Ellis, D. Darby, D. Ames, and et al. Abeta and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease Alzheimers Dement 10 2014 743 751.e1
8. C.H. Kawas, D.E. Greenia, S.S. Bullain, C.M. Clark, M.J. Pontecorvo, A.D. Joshi, and et al. Amyloid imaging and cognitive decline in nondemented oldest-old: The 90+ study Alzheimers Dement 9 2013 199 203
9. P.M. Doraiswamy, R.A. Sperling, K. Johnson, E.M. Reiman, T.Z. Wong, M.N. Sabbagh, and et al. Florbetapir F 18 amyloid PET and 36-month cognitive decline: A prospective multicenter study Mol Psychiatry 19 2014 1044 1051
10. V.L. Villemagne, K.E. Pike, G. Chetelat, K.A. Ellis, R.S. Mulligan, P. Bourgeat, and et al. Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease Ann Neurol 69 2011 181 192
11. E.C. Mormino, R.A. Betensky, T. Hedden, A.P. Schultz, A. Ward, W. Huijbers, and et al. Amyloid and APOE epsilon4 interact to influence short-term decline in preclinical Alzheimer disease Neurology 82 2014 1760 1767
12. K.M. Rodrigue, K.M. Kennedy, M.D. Devous Sr., J.R. Rieck, A.C. Hebrank, R. Diaz-Arrastia, and et al. β-Amyloid burden in healthy aging: Regional distribution and cognitive consequences Neurology 78 2012 387 395
13. M.M. Machulda, V.S. Pankratz, T.J. Christianson, R.J. Ivnik, M.M. Mielke, R.O. Roberts, and et al. Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging Clin Neuropsychol 27 2013 1247 1264
14. P.J. Snyder, C.E. Jackson, R.C. Petersen, A.S. Khachaturian, J. Kaye, M.S. Albert, and et al. Assessment of cognition in mild cognitive impairment: A comparative study Alzheimers Dement 7 2011 338 355
15. K. Wild, D. Howieson, F. Webbe, A. Seelye, and J. Kaye Status of computerized cognitive testing in aging: A systematic review Alzheimers Dement 4 2008 428 437
16. M.M. Mielke, M.M. Machulda, C.E. Hagen, K.K. Edwards, R.O. Roberts, V.S. Pankratz, and et al. Performance of the CogState computerized battery in the Mayo Clinic Study on Aging Alzheimers Dement 11 2015 1367 1376
17. R.O. Roberts, Y.E. Geda, D.S. Knopman, R.H. Cha, V.S. Pankratz, B.F. Boeve, and et al. The Mayo Clinic Study of Aging: Design and sampling, participation, baseline measures and sample characteristics Neuroepidemiology 30 2008 58 69
18. E. Kokmen, G.E. Smith, R.C. Petersen, E. Tangalos, and R.C. Ivnik The short test of mental status. Correlations with standardized psychometric testing Arch Neurol 48 1991 725 728
19. J.C. Morris The Clinical Dementia Rating (CDR): Current version and scoring rules Neurology 43 1993 2412 2414
20. A. Rey L'examen clinique en psychologie 1964 Presses Universitaires de France Paris
21. D. Wechsler Manual for the Wechsler memory scale-revised 1987 The Psychological Corporation San Antonio, TX
22. E. Kaplan, H. Goodglass, and S. Weintraub The boston naming test 1983 Lea & Febiger Philadelphia
23. E. Strauss, E.M.S. Sherman, and O. Spreen A compendium of neuropsychological tests 2006 Oxford University Press New York
24. R. Reitan Validity of the trail making test as an indicator of organic brain damage Percept Mot Skills 8 1958 271 276
25. D. Wechsler Wechsler adult intelligence scale-revised [manual] 1981 Psychological Corporation San Antonio, TX
26. R.J. Ivnik, J.F. Malec, G.E. Smith, E.G. Tangalos, R.C. Petersen, E. Kokmen, and et al. Mayo's older Americans normative studies: WAIS-R norms for ages 56 to 97 Clin Neuropsychol 6 1992 1 30
27. R.C. Petersen, R.O. Roberts, D.S. Knopman, Y.E. Geda, R.H. Cha, V.S. Pankratz, and et al. Prevalence of mild cognitive impairment is higher in men: The Mayo Clinic Study of Aging Neurology 75 2010 889 897
28. M.M. Mielke, S.D. Weigand, H.J. Wiste, P. Vemuri, M.M. Machulda, D.S. Knopman, and et al. Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging Alzheimers Dement 10 2014 779 789
29. A. Collie, P. Maruff, D.G. Darby, and M. McStephen The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals J Int Neuropsychol Soc 9 2003 419 428
30. C.R. Jack Jr., H.J. Wiste, S.D. Weigand, D.S. Knopman, V. Lowe, P. Vemuri, and et al. Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity Neurology 81 2013 1732 1740
31. R.J. Caselli, A.C. Dueck, D. Osborne, M.N. Sabbagh, D.J. Connor, G.L. Ahern, and et al. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect N Engl J Med 361 2009 255 263
32. O.J. Schiepers, S.E. Harris, A.J. Gow, A. Pattie, C.E. Brett, J.M. Starr, and et al. APOE E4 status predicts age-related cognitive decline in the ninth decade: Longitudinal follow-up of the Lothian Birth Cohort 1921 Mol Psychiatry 17 2012 315 324
33. N.A. Kozauer, M.M. Mielke, G.K. Chan, G.W. Rebok, and C.G. Lyketsos Apolipoprotein E genotype and lifetime cognitive decline Int Psychogeriatr 20 2008 109 123
34. D. Bunce, L. Fratiglioni, B.J. Small, B. Winblad, and L. Backman APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging Neurology 63 2004 816 821
35. T. Hedden, H. Oh, A.P. Younger, and T.A. Patel Meta-analysis of amyloid-cognition relations in cognitively normal older adults Neurology 80 2013 1341 1348
36. C.R. Jack Jr., H.J. Wiste, S.D. Weigand, D.S. Knopman, P. Vemuri, M.M. Mielke, and et al. Age, sex, and APOE epsilon4 effects on memory, brain structure, and beta-amyloid across the adult life span JAMA Neurol 72 2015 511 519
37. W.A. Rocca, R.C. Petersen, D.S. Knopman, L.E. Hebert, D.A. Evans, K.S. Hall, and et al. Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States Alzheimers Dement 7 2011 80 93
38. A.F. Jorm, and D. Jolley The incidence of dementia: A meta-analysis Neurology 51 1998 728 733
39. S.C. Johnson, B.T. Christian, O.C. Okonkwo, J.M. Oh, S. Harding, G. Xu, and et al. Amyloid burden and neural function in people at risk for Alzheimer's disease Neurobiol Aging 35 2014 576 584
40. M.G. Harrington, J. Chiang, J.M. Pogoda, M. Gomez, K. Thomas, S.D. Marion, and et al. Executive function changes before memory in preclinical Alzheimer's pathology: A prospective, cross-sectional, case control study PLoS One 8 2013 e79378
41. M.C. Carlson, Q.L. Xue, J. Zhou, and L.P. Fried Executive decline and dysfunction precedes declines in memory: The Women's Health and Aging Study II J Gerontol A Biol Sci Med Sci 64 2009 110 117
42. A.D. Baddeley, S. Bressi, S. Della Sala, R. Logie, and H. Spinnler The decline of working memory in Alzheimer's disease. A longitudinal study Brain 114 Pt 6 1991 2521 2542
43. N. Ayutyanont, J.B. Langbaum, S.B. Hendrix, K. Chen, A.S. Fleisher, M. Friesenhahn, and et al. The Alzheimer's prevention initiative composite cognitive test score: Sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers J Clin Psychiatry 75 2014 652 660
44. J.B. Langbaum, S.B. Hendrix, N. Ayutyanont, K. Chen, A.S. Fleisher, R.C. Shah, and et al. An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease Alzheimers Dement 10 2014 666 674
45. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, R.C. Petersen, M.W. Weiner, P.S. Aisen, and et al. Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers Lancet Neurol 12 2013 207 216